These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18165635)

  • 1. Randomized trials in oncology stopped early for benefit.
    Wilcox RA; Djulbegovic B; Moffitt HL; Guyatt GH; Montori VM
    J Clin Oncol; 2008 Jan; 26(1):18-9. PubMed ID: 18165635
    [No Abstract]   [Full Text] [Related]  

  • 2. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim monitoring of efficacy data is important and appropriate.
    Sydes MR; Parmar MK
    J Clin Epidemiol; 2008 Mar; 61(3):203-4. PubMed ID: 18226741
    [No Abstract]   [Full Text] [Related]  

  • 6. More on data monitoring and large apparent treatment effects.
    Anderson JR
    Contemp Clin Trials; 2005 Jun; 26(3):416-7. PubMed ID: 15911475
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring clinical trials. Interim data should not be publicly available.
    Richards SM
    BMJ; 2001 Dec; 323(7326):1424. PubMed ID: 11778588
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials in adult AML.
    Stock W
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporating novel treatment strategies into conventional therapy.
    Estey EH
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):4-7. PubMed ID: 19645129
    [No Abstract]   [Full Text] [Related]  

  • 10. The long road to a cure for acute myelocytic leukemia: from intensity to specificity.
    Vaughan WP; Karp JE
    J Clin Oncol; 2008 Jul; 26(21):3475-7. PubMed ID: 18640926
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 12. The power of comparative studies.
    Walter RB; Estey EH
    Leuk Res; 2009 May; 33(5):610-2. PubMed ID: 18990445
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of AMSA in acute leukemia.
    Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
    Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel strategies for relapsed and refractory acute myeloid leukemia.
    Mato AR; Morgans A; Luger SM
    Curr Opin Hematol; 2008 Mar; 15(2):108-14. PubMed ID: 18300756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data monitoring and large apparent treatment effects.
    Korn EL; Freidlin B; George SL
    Control Clin Trials; 2004 Feb; 25(1):67-9; author reply 71-2. PubMed ID: 14980749
    [No Abstract]   [Full Text] [Related]  

  • 16. Early discharge from hospital after consolidation chemotherapy in acute myeloid leukemia in remission: febrile neutropenic episodes and their outcome in a resource poor setting.
    Naithani R; Kumar R; Mahapatra M; Agrawal N; Mishra P
    Haematologica; 2008 Sep; 93(9):1416-8. PubMed ID: 18603560
    [No Abstract]   [Full Text] [Related]  

  • 17. Stopping rules for clinical trials.
    Whitehead J
    Control Clin Trials; 2004 Feb; 25(1):69-70; author reply 71-2. PubMed ID: 14980750
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion.
    Peñarrubia MJ; Silvestre LA; Conde J; Cantalapiedra A; Garcia Frade LJ
    Leuk Res; 2009 Jun; 33(6):e8-9. PubMed ID: 19168219
    [No Abstract]   [Full Text] [Related]  

  • 19. Interim analysis in randomized trials: DAMOCLES' sword?
    Besselink MG; van der Graaf Y; Gooszen HG
    J Clin Epidemiol; 2010 Apr; 63(4):353-4. PubMed ID: 19959333
    [No Abstract]   [Full Text] [Related]  

  • 20. Early viewing of noninferiority trials in progress.
    Dignam JJ
    J Clin Oncol; 2005 Aug; 23(24):5461-3. PubMed ID: 16027438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.